Integration of Implantable Device Therapy in Patients with Heart Failure. A Clinical Consensus Statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)

Mullens, W; Dauw, J; Gustafsson, F; Mebazaa, A; Steffel, J; Witte, KK; Delgado, V; Linde, C; Vernooy, K; Anker, SD; Chioncel, O; Milicic, D; Hasenfuß, G; Ponikowski, P; von Bardeleben, RS; Koehler, F; Ruschitzka, F; Damman, K; Schwammenthal, E; Testani, JM; Zannad, F; Böhm, M; Cowie, MR; Dickstein, K; Jaarsma, T; Filippatos, G; Volterrani, M; Thum, T; Adamopoulos, S; Cohen-Solal, A; Moura, B; Rakisheva, A; Ristic, A; Bayes-Genis, A; Van Linthout, S; Tocchetti, CG; Savarese, G; Skouri, H; Adamo, M; Amir, O; Yilmaz, MB; Simpson, M; Tokmakova, M; González, A; Piepoli, M; Seferovic, P; Metra, M; Coats, AJS; Rosano, GMC

doi:10.1002/ejhf.3150

Heart failure & cardiomyopathies

Integration of Implantable Device Therapy in Patients with Heart Failure. A Clinical Consensus Statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC)

Eur J Heart FailPublished 25 Jan 2024Clinical consensus statement

Read the original article ↗PubMed

Cite

Recommendations

As issued by the authors

Some devices might be considered early in the heart failure (HF) disease trajectory, others reserved for advanced HF
Device therapy should be integrated into HF care programmes

Reference

Issued by: Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the ESC
Document: Clinical consensus statement
Scope: Integration of implantable device therapy in HF care: physiological rationale, device-guided management, overview of guideline-recommended devices, new integrated model

Authors: Mullens W, Dauw J, Gustafsson F, Mebazaa A, Steffel J, Witte KK, et al.
All 49 authors
Mullens W, Dauw J, Gustafsson F, Mebazaa A, Steffel J, Witte KK, Delgado V, Linde C, Vernooy K, Anker SD, Chioncel O, Milicic D, Hasenfuß G, Ponikowski P, von Bardeleben RS, Koehler F, Ruschitzka F, Damman K, Schwammenthal E, Testani JM, Zannad F, Böhm M, Cowie MR, Dickstein K, Jaarsma T, Filippatos G, Volterrani M, Thum T, Adamopoulos S, Cohen-Solal A, Moura B, Rakisheva A, Ristic A, Bayes-Genis A, Van Linthout S, Tocchetti CG, Savarese G, Skouri H, Adamo M, Amir O, Yilmaz MB, Simpson M, Tokmakova M, González A, Piepoli M, Seferovic P, Metra M, Coats AJS, Rosano GMC
Journal: European Journal of Heart Failure
Published: 25 Jan 2024
DOI: 10.1002/ejhf.3150
PubMed: 38269474

Topic: Heart failure & cardiomyopathies

Original publication

Integration of Implantable Device Therapy in Patients with Heart Failure. A Clinical Consensus Statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). Eur J Heart Fail. Published 25 January 2024. doi:10.1002/ejhf.3150

Read the original article ↗

Composed by AI from the published abstract and checked against it. How Briefs are made →